Bicycle Therapeutics Plc - ADR

NASDAQ:BCYC  
19.78
+0.09 (+0.46%)
Products

Bicycle Therapeutics Announces Settlement Of Patent Dispute With Pepscan Systems B.V.

Published: 11/20/2020 21:14 GMT
Bicycle Therapeutics PLC (BCYC) - Bicycle Therapeutics Announces Settlement of Patent Dispute With Pepscan Systems Bvbicycle Therapeutics Plc - Entered Into Settlement & License Agreement Regarding Co 's Use of Pepscan's Clips Peptide Technology.
Bicycle Therapeutics Plc - Co Will Pay EUR 3 Million Upfront, Will Pay EUR 1 Million on First Anniversary of Date of Settlement.
Bicycle Therapeutics Plc - Granted License to Use Clips Peptide Technology in Development of Its Product Candidates Bt1718 and Thr-149.